Although the adjusted hazard ratio for MACE did not reach statistical significance, the higher incidence rate among individuals who developed diabetes during statin therapy suggests a potential signal that merits longer-term follow-up.
← all excerpts
Cardiovascular outcomes associated with incident diabetes during statin therapy: a nationwide propensity-matched cohort study.
1
—
—